About this item
Product details
Diampa LXR is a high-potency, triple-combination oral medication for the intensive management of type 2 diabetes in adults. This formulation features the maximum therapeutic dose of Empagliflozin (25mg), combined with Linagliptin (5mg) and a full 1000mg dose of Metformin. It is designed for patients who require robust glycemic control and who may benefit from the significant cardiovascular and renal protective effects associated with high-dose Empagliflozin therapy, all within a single once-daily tablet. Maximum SGLT2 Inhibition: The 25mg Empagliflozin dose provides the highest level of urinary glucose excretion for powerful and sustained blood sugar lowering. Comprehensive Multi-Mechanism Action: Targets blood glucose through three distinct and complementary pathways for superior glycemic management. Cardiovascular & Renal Protection: Empagliflozin at this dose is strongly associated with reduced risk of major cardiovascular events and progression of kidney disease in patients with type 2 diabetes. Composition Each film-coated tablet contains: Empagliflozin: 25 mg Linagliptin: 5 mg Metformin HCI USP: 1000 mg (as extended release) Directions for Use As directed by the physician.
- Medicines
- 14 Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 08964003891596
- Variant
- 14 Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
